zinc pyrithione 6 MG/ML

RxCUI
1485891
RxNorm name
zinc pyrithione 6 MG/ML
Term type
SCDC
Status
Active
Updated
2026-10-20 20:48:04

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
022014
Active start
022014
Multiple ingredient
NO
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
6 MG / 1 MLzinc pyrithione

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
zinc pyrithione39952

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
RXNAV_STRzinc pyrithione 6 MG/ML1NAMES
RxNorm Namezinc pyrithione 6 MG/ML1NAMES
TTYSCDC1ATTRIBUTES
RxCUI14858911CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCD11AXOther dermatologicalsATC1-4zinc pyrithione
MEDRTD009942Organometallic CompoundsCHEMhas_ingredientzinc pyrithione
MEDRTD011725PyridinesCHEMhas_ingredientzinc pyrithione
MEDRTD063807DandruffDISEASEmay_preventzinc pyrithione
MEDRTD063807DandruffDISEASEmay_treatzinc pyrithione
MEDRTD012628Dermatitis, SeborrheicDISEASEmay_treatzinc pyrithione
MEDRTD004342Drug HypersensitivityDISEASEci_withzinc pyrithione
MEDRTN0000000147Proton Pump InhibitorsMOAhas_moazinc pyrithione
MEDRTN0000009915Unknown Cellular or Molecular InteractionMOAhas_moazinc pyrithione
MEDRTN0000008476Decreased Cell Membrane IntegrityPEhas_pezinc pyrithione
MEDRTN0000008732Decreased MitosisPEhas_pezinc pyrithione

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYHYBRID
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSTRENGTH6 MG/ML